📰 Iagnostics News
Page 13 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
October 6, 2023
A partnership comprising software company Euformatics, ViennaLab Diagnostics and Oncompass Medicine, have been awarded with one of three Phase 2 contracts to research and develop an economically sustainable liquid biopsy diagnostics solution based on DNA and RNA molecular profiling in cancer patients for a buyer consortium including some of the highest ranking European hospitals(1) from Germany, France, Italy, Spain and Belgium for the OncNGS pre-commercial procurement Consortium funded by the E...
October 6, 2023
Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve existing care strategies.
October 5, 2023
The key to cancer survival rates is closely tied to early detection, and at the Purchase District Health Department, they are helping people locally get access to the most advanced
October 2, 2023
The FDA awarded marketing authorization for a new Invitae test that uses next-generation sequencing to assess multiple genes to identify variants indicating a person’s predisposition for certain cancers. The regulatory action creates a new regulatory classification making Invitae’s test the predicate device for future cancer tests.
September 29, 2023
Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The
September 29, 2023
Patients in some of the most deprived areas of England, where respiratory conditions including chronic lung disease (COPD) and asthma are most prevalent, have limited or no access to vital diagnostic tests to confirm their diagnosis, reveals a survey by The BMJ today.
September 25, 2023
Kirin is looking to back innovations in metabolic health, immunity and brain function, fermentation and microbiota control, and consumer health data technology through its startup innovation fund.
September 25, 2023
An advanced artificial Intelligence (AI) system designed to interpret fundus fluorescein angiography (FFA) images precisely.
September 25, 2023
Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group (headquartered in Japan), announce the opening of the Pathology Innovation Incubator in Budapest to develop methods and equipment for faster and more precise diagnosis of cancer and tumor lesions.
September 23, 2023
Researchers have made a significant finding in determining the genetic background of dilated cardiomyopathy in Dobermanns.